The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogen in the management of metastatic prostatic cancer
- 1 June 1994
- Vol. 43 (6) , 834-837
- https://doi.org/10.1016/0090-4295(94)90145-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosteroneUrology, 1992
- Advanced Prostatic CarcinomaUrologic Clinics of North America, 1991
- Flushing long-term side effect of orchiectomy in treatment of prostatic carcinomaUrology, 1989
- Effectiveness of Castration Versus Intravenous Estrogen Therapy in Producing Rapid Endocrine Control of Metastatic Cancer of the ProstateJournal of Urology, 1985
- Hormonal Therapy of Prostatic CancerCancer, 1980
- Effects of Estrogens on the Testosterone Levels of peripheral and Spermatic Vein Blood in Patients With Prostatic CancerJournal of Urology, 1979
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973
- Estrogen Dosage and Suppression of Testosterone Levels in Patients with Prostatic CarcinomaJournal of Urology, 1973
- Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic CarcinomaBMJ, 1971
- Plasma Testosterone Levels in Patients with Prostatic Carcinoma Before and after TreatmentJournal of Urology, 1968